Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Edaravone activates the GDNF/RET neurotrophic signaling pathway and protects mRNA-induced motor neurons from iPS cells

Qian Li, Yi Feng, Yingchao Xue, Xiping Zhan, Yi Fu, Gege Gui, Jean-Philippe Richard, Arens Taga, Xiaobo Mao, Nicholas J. Maragakis, Mingyao Ying
doi: https://doi.org/10.1101/2021.05.09.443325
Qian Li
1Department of Endocrinology, Key Laboratory of Endocrinology, NHC, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 100730
2Hugo W. Moser Research Institute at Kennedy Krieger, Baltimore, Maryland, USA, 21205
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yi Feng
2Hugo W. Moser Research Institute at Kennedy Krieger, Baltimore, Maryland, USA, 21205
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yingchao Xue
2Hugo W. Moser Research Institute at Kennedy Krieger, Baltimore, Maryland, USA, 21205
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiping Zhan
4Department of Physiology and Biophysics, Howard University, Washington, DC, USA, 20059
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yi Fu
1Department of Endocrinology, Key Laboratory of Endocrinology, NHC, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 100730
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gege Gui
5Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA, 21205
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Philippe Richard
3Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA, 21205
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arens Taga
3Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA, 21205
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaobo Mao
3Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA, 21205
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas J. Maragakis
3Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA, 21205
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mingyao Ying
2Hugo W. Moser Research Institute at Kennedy Krieger, Baltimore, Maryland, USA, 21205
3Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA, 21205
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ying@kennedykrieger.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Preview PDF
Loading

Abstract

Background Spinal cord motor neurons (MNs) from human iPS cells (iPSCs) have wide applications in disease modeling and therapeutic development for amyotrophic lateral sclerosis (ALS) and other MN-associated neurodegenerative diseases. We need highly efficient MN differentiation strategies for generating iPSC-derived disease models that closely recapitulate the genetic and phenotypic complexity of ALS. An important application of these models is to understand molecular mechanisms of action of FDA-approved ALS drugs that only show modest clinical efficacy. Novel mechanistic insights will help us design optimal therapeutic strategies together with predictive biomarkers to achieve better efficacy.

Methods We induce efficient MN differentiation from iPSCs in 4 days using synthetic mRNAs coding two transcription factors (Ngn2 and Olig2) with phosphosite modification. These MNs after extensive characterization were applied in electrophysiological and neurotoxicity assays as well as transcriptomic analysis, to study the neuroprotective effect and molecular mechanisms of edaravone, an FDA-approved drug for ALS, for improving its clinical efficacy.

Results We generate highly pure and functional mRNA-induced MNs (miMNs) from normal and ALS iPSCs, as well as embryonic stem cells. Edaravone alleviates H2O2-induced neurotoxicity and electrophysiological dysfunction in miMNs, demonstrating its neuroprotective effect. Guided by the transcriptomic analysis, we show a previously unrecognized effect of edaravone to induce the GDNF receptor RET and the GDNF/RET neurotrophic signaling in vitro and in vivo, suggesting a clinically translatable strategy to activate this key neuroprotective signaling. Notably, edaravone can replace required neurotrophic factors (BDNF and GDNF) to support long-term miMN survival and maturation, further supporting the neurotrophic function of edaravone-activated signaling. Furthermore, we show that edaravone and GDNF combined treatment more effectively protects miMNs from H2O2-induced neurotoxicity than single treatment, suggesting a potential combination strategy for ALS treatment.

Conclusions This study provides methodology to facilitate iPSC differentiation and disease modeling. Our discoveries will facilitate the development of optimal edaravone-based therapies for ALS and potentially other neurodegenerative diseases.

Figure
  • Download figure
  • Open in new tab

Competing Interest Statement

The authors have declared no competing interest.

Footnotes

  • Disclosure of Potential Conflicts of Interest: The authors declare no potential conflicts of interest.

  • (liqianpumch{at}163.com), (orchidfy{at}hotmail.com), (yxue8{at}jhmi.edu), (xiping.zhan{at}howard.edu), (fuy{at}kennedykrieger.org), (guigege01{at}gmail.com), (JeanPhilippe.Richard{at}reprocell.com), (ataga1{at}jhmi.edu), (xmao4{at}jhmi.edu), (nmaragak{at}jhmi.edu), (ying{at}kennedykrieger.org)

  • List of abbreviations

    iPSC
    induced pluripotent stem cell
    ESC
    embryonic stem cell
    PSC
    pluripotent stem cell
    MN
    motor neuron
    ALS
    amyotrophic lateral sclerosis
    miMN
    mRNA-induced motor neuron
    FDA
    the Food and Drug Administration
    TF
    transcription factor
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted May 10, 2021.
    Download PDF
    Email

    Thank you for your interest in spreading the word about bioRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Edaravone activates the GDNF/RET neurotrophic signaling pathway and protects mRNA-induced motor neurons from iPS cells
    (Your Name) has forwarded a page to you from bioRxiv
    (Your Name) thought you would like to see this page from the bioRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Edaravone activates the GDNF/RET neurotrophic signaling pathway and protects mRNA-induced motor neurons from iPS cells
    Qian Li, Yi Feng, Yingchao Xue, Xiping Zhan, Yi Fu, Gege Gui, Jean-Philippe Richard, Arens Taga, Xiaobo Mao, Nicholas J. Maragakis, Mingyao Ying
    bioRxiv 2021.05.09.443325; doi: https://doi.org/10.1101/2021.05.09.443325
    Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
    Citation Tools
    Edaravone activates the GDNF/RET neurotrophic signaling pathway and protects mRNA-induced motor neurons from iPS cells
    Qian Li, Yi Feng, Yingchao Xue, Xiping Zhan, Yi Fu, Gege Gui, Jean-Philippe Richard, Arens Taga, Xiaobo Mao, Nicholas J. Maragakis, Mingyao Ying
    bioRxiv 2021.05.09.443325; doi: https://doi.org/10.1101/2021.05.09.443325

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Neuroscience
    Subject Areas
    All Articles
    • Animal Behavior and Cognition (3477)
    • Biochemistry (7315)
    • Bioengineering (5290)
    • Bioinformatics (20180)
    • Biophysics (9967)
    • Cancer Biology (7696)
    • Cell Biology (11242)
    • Clinical Trials (138)
    • Developmental Biology (6413)
    • Ecology (9910)
    • Epidemiology (2065)
    • Evolutionary Biology (13266)
    • Genetics (9346)
    • Genomics (12542)
    • Immunology (7665)
    • Microbiology (18919)
    • Molecular Biology (7413)
    • Neuroscience (40853)
    • Paleontology (298)
    • Pathology (1224)
    • Pharmacology and Toxicology (2124)
    • Physiology (3137)
    • Plant Biology (6833)
    • Scientific Communication and Education (1268)
    • Synthetic Biology (1890)
    • Systems Biology (5295)
    • Zoology (1083)